Amotivation

Amotivational syndrome is characterized by detachment, blunted emotion and drives, and executive functions like memory and attention are impaired; it is primarily associated with long-term effects of cannabis use. The amotivational syndrome associated with Cannabis, characterized by reduced motivation to perform the activities of daily living, disorders of concentration and attention, and blunting of affect, has been insufficiently investigated to date (2015) and empirical proof is lacking. Pacheco-Colón et al. (2018) concludes: .mw-parser-output .templatequote{overflow:hidden;margin:1em 0;padding:0 40px}.mw-parser-output .templatequote .templatequotecite{line-height:1.5em;text-align:left;padding-left:1.6em;margin-top:0}In conclusion, studies examining the effects of cannabis use on motivation and reward sensitivity have yielded mixed findings. We conclude that cross-sectional evidence supporting the presence of amotivational syndrome among cannabis users or an adverse cannabis-specific effect on motivation is currently equivocal. Amotivational syndrome is characterized by detachment, blunted emotion and drives, and executive functions like memory and attention are impaired; it is primarily associated with long-term effects of cannabis use. The amotivational syndrome associated with Cannabis, characterized by reduced motivation to perform the activities of daily living, disorders of concentration and attention, and blunting of affect, has been insufficiently investigated to date (2015) and empirical proof is lacking. Pacheco-Colón et al. (2018) concludes: .mw-parser-output .templatequote{overflow:hidden;margin:1em 0;padding:0 40px}.mw-parser-output .templatequote .templatequotecite{line-height:1.5em;text-align:left;padding-left:1.6em;margin-top:0} According to the Handbook of Clinical Psychopharmacology for Therapists, amotivational syndrome is listed as a possible side effect of SSRIs in the treatment of clinical depression.